KFS
CUE icon

Kelly Financial Services’s Cue Biopharma CUE Stock Holding History

Kelly Financial Services’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17
Closed -$620 – 240
2024
Q2 		$620 Hold
17
– – ﹤0.01% 694
2024
Q1 		$945 Hold
17
– – ﹤0.01% 681
2023
Q4 		$1.32K Hold
17
– – ﹤0.01% 628
2023
Q3 		$1.15K Hold
17
– – ﹤0.01% 609
2023
Q2 		$1.82K Hold
17
– – ﹤0.01% 558
2023
Q1 		$1.78K Hold
17
– – ﹤0.01% 536
2022
Q4 		$1.43K Buy
17
+7
+70% +$640 ﹤0.01% 533
2022
Q3 		$669 Hold
10
– – ﹤0.01% 595
2022
Q2 		$747 Hold
10
– – ﹤0.01% 579
2022
Q1 		$1.46K Hold
10
– – ﹤0.01% 552
2021
Q4 		$3.39K Buy
+10
New +$3.87K ﹤0.01% 486

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Kelly Financial Services's CUE Position: Q3 2024 in Review

Kelly Financial Services sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 17 shares — an estimated $620 sold.

Kelly Financial Services first reported a position in CUE in Q4 2021 and held it in 11 quarters. The position peaked at $3.39K in Q4 2021. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • Kelly Financial Services reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 17 Cue Biopharma shares in Q3 2024, an estimated $620.
  • Kelly Financial Services first reported a position in Cue Biopharma in Q4 2021 and held it in 11 quarters.
  • Kelly Financial Services's Cue Biopharma position peaked at $3.39K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.